These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 18388685)

  • 41. Critical issues in bioartificial liver development.
    Tilles AW; Berthiaume F; Yarmush ML; Toner M
    Technol Health Care; 2002; 10(3-4):177-86. PubMed ID: 12118141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver.
    van de Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Scala D; Scala S; Zeuli L; Di Nicuolo G; Amoroso P; Calise F; Chamuleau RA
    Cell Transplant; 2003; 12(6):563-8. PubMed ID: 14579924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular adsorbent recirculating system and bioartificial devices for liver failure.
    Bañares R; Catalina MV; Vaquero J
    Clin Liver Dis; 2014 Nov; 18(4):945-56. PubMed ID: 25438293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The clinical experience with MARS and Prometheus procedures].
    Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
    Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Artificial liver support devices for fulminant liver failure.
    Sechser A; Osorio J; Freise C; Osorio RW
    Clin Liver Dis; 2001 May; 5(2):415-30. PubMed ID: 11385970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Albumin dialysis: an update.
    Mitzner SR
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):589-95. PubMed ID: 18089976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results.
    Skwarek A; Grodzicki M; Nyckowski P; Kotulski M; Zieniewicz K; Michalowicz B; Patkowski W; Grzelak I; Paczkowska A; Giercuszkiewicz D; Sańko-Resmer J; Paczek L; Krawczyk M
    Transplant Proc; 2006; 38(1):209-11. PubMed ID: 16504704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning.
    Kantola T; Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):399-403. PubMed ID: 19788456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model.
    Frühauf NR; Oldhafer KJ; Höltje M; Kaiser GM; Frühauf JH; Stavrou GA; Bader A; Broelsch CE
    Surgery; 2004 Jul; 136(1):47-56. PubMed ID: 15232539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Artificial liver support: a real step forward.
    Saliba F; Samuel D
    Minerva Med; 2015 Feb; 106(1):35-43. PubMed ID: 25367058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
    Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
    ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mars and Prometheus: our clinical experience in acute chronic liver failure.
    Faenza S; Baraldi O; Bernardi M; Bolondi L; Coli L; Cucchetti A; Donati G; Gozzetti F; Lauro A; Mancini E; Pinna AD; Piscaglia F; Rasciti L; Ravaioli M; Ruggeri G; Santoro A; Stefoni S
    Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review article: non-biological liver support in liver failure.
    Laleman W; Wilmer A; Evenepoel P; Verslype C; Fevery J; Nevens F
    Aliment Pharmacol Ther; 2006 Feb; 23(3):351-63. PubMed ID: 16422994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracorporeal liver support: waiting for the deciding vote.
    Adham M
    ASAIO J; 2003; 49(6):621-32. PubMed ID: 14655724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver support systems: promise and reality.
    Wigg AJ; Padbury RT
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1807-16. PubMed ID: 16336437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A bioartificial liver--state of the art.
    Strain AJ; Neuberger JM
    Science; 2002 Feb; 295(5557):1005-9. PubMed ID: 11834813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute-on-chronic liver failure: extracorporeal liver assist devices.
    Hassanein TI; Schade RR; Hepburn IS
    Curr Opin Crit Care; 2011 Apr; 17(2):195-203. PubMed ID: 21346566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.
    Inoue K; Kourin A; Watanabe T; Yamada M; Yoshiba M
    Transplant Proc; 2009; 41(1):259-61. PubMed ID: 19249529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Artificial liver support systems: state of the art].
    Pazzi P; Scagliarini R
    Ann Ital Chir; 2000; 71(3):319-23. PubMed ID: 11014011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hybrid (bioartificial) systems for liver support. History and current developments].
    Morsiani E
    Ann Ital Chir; 2000; 71(3):311-8. PubMed ID: 11014010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.